3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
3
Myeloid
3
Lymphoid
3
Other neoplasm
2
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
NET
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Brain Neoplasms
3
Radiation Injuries
2
Cognitive Dysfunction
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Interventions
Psychiatric Rehabilitation
7
Cyclophosphamide
7
Melphalan
6
Radiotherapy
5
Methylprednisolone
5
Flow Cytometry
5
Busulfan
5
Therapeutics
4
Filgrastim
4
sargramostim
3
Topotecan
3
Rituximab
3
Polymerase Chain Reaction
3
Early Intervention, Educational
3
Drug Therapy
3
Dexamethasone
3
Caspofungin
3
Calcium Dobesilate
3
Antilymphocyte Serum
3
venetoclax
2
thymoglobulin
2
tanespimycin
2
liposomal amphotericin B
2
fludarabine
2
Vorinostat
2
Voriconazole
2
Thiotepa
2
Peripheral Blood Stem Cell Transplantation
2
Ondansetron
2
Methylphenidate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Patient Reported Outcome Measures
×
CNS
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled